Seattle Genetics (SGEN) Tops Q4 EPS by 59c, Revenues Beat; Offers FY20 Sales Outlook Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/4/2026

1. NKE
2. USO
3. SPY
4. ACN
5. NVDA
6. FICO
7. TRU
8. TLT
9. LAES
10. WBD

Go back to Seattle Genetics (SGEN) Tops Q4 EPS by 59c, Revenues Beat; Offers FY20 Sales Outlook Below Consensus

Seattle Genetics (SGEN) PT Raised to $120 at RBC Capital

February 5, 2020 6:26 AM EST

RBC Capital analyst Kennen MacKay raised the price target on Seattle Genetics (NASDAQ: SGEN) to $120.00 (from $113.00) while maintaining a Outperform rating.... More